Antimicrob Agents Chemother HARFOOT R, Lawley B, Hernandez LC, Kuang J, et al Synthetic host defense peptide inhibits SARS-CoV-2 replication in vitro. Antimicrob Agents Chemother. 2025;69:e0170024. PubMed Abstract available TATE M, Illingworth CJR, MacGregor G, Cunningham L, et al Clinical effectiveness, safety, and viral mutagenicity of oral favipiravir for COVID-19: results from a community-based, open-label, randomized Phase III trial. Antimicrob Agents Chemother. 2025;69:e0005425. PubMed Abstract available ZHOU Y, Meng X, Li J, Zeng G, et al Safety, tolerability, and pharmacokinetics of anti-SARS-CoV-2 monoclonal antibody SA55 injection in healthy participants. Antimicrob Agents Chemother. 2025;69:e0056825. PubMed Abstract available GOMI S, Price E, Burgoyne H, Faozia S, et al Omadacycline exhibits anti-inflammatory properties a...